FDA grants Roches TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer

21st April 2017 Uncategorised 0

Roche

More: FDA grants Roches TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer
Source: MDlinx